Form 4: Merit Medical Director Receives RSU Grant

Director Laura S. Kaiser was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.

Summary

• Director Laura S. Kaiser received a grant of 3,457 restricted stock units (RSUs) on May 18, 2026.
• The grant was issued under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
• Following this transaction, the director's total beneficial ownership of common stock increased to 13,352 shares.
• The RSUs are scheduled to vest on May 3, 2027, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.
• The director maintains a direct ownership stake of 13,352 shares.

Negatives

• None identified.

Risks

• Vesting of the RSUs is contingent upon the director's continued service to the issuer through May 3, 2027.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to ensure long-term alignment between board members and shareholders in the medical device sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for mid-cap medical technology companies.
• The vesting period of approximately one year is typical for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 3,457 RSUs on May 3, 2027.

Key Dates

Keywords

Merit Medical Systems, MMSI, Form 4, Director Compensation, Restricted Stock Units, Equity Incentive Plan